ArticleOncotarget2015

PARP inhibitor ABT-888 affects response of MDA-MB-231 cells to doxorubicin treatment, targeting Snail expression.

Germano Mariano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.